New Delhi: With some Congress leaders raising concerns over the grant of approval to Bharat Biotech‘s COVID-19 vaccine, Health Minister Harsh Vardhan asserted on Sunday that Covaxin is more likely to work against newer variants of the virus, including the UK variant, and asked politicians not to ”discredit well laid out science-backed protocols” followed for approving the jab. Some Congress leaders, […]
Read MoreNew Delhi : The approval given to two COVID-19 vaccines is a ”decisive turning point” in the spirited fight against the pandemic, Prime Minister Narendra Modi said on Sunday as the development was greeted with a sense of relief and hope in the country that has been reeling from the impact of the virus for […]
Read MoreNew Delhi: India’s drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive. The Drugs Controller General of India (DCGI) granted the approval on the basis of recommendations by a COVID-19 Subject Expert Committee (SEC) […]
Read MoreNew Delhi: As India came closer to the roll-out of COVID-19 vaccine, a dry run was held by all states and union territories on Saturday in preparation for a massive inoculation drive, with Health Minister Harsh Vardhan appealing to people not to be misguided by ”rumours” and disinformation regarding the safety and efficacy of the vaccine. Vardhan said that […]
Read MoreNew Delhi: Union Health Minister Harsh Vardhan on Monday launched the country’s first pneumococcal conjugate vaccine ‘Pneumosil’ developed by Serum Institute of India in collaboration with partners like the Bill and Melinda Gates Foundation. Recognising the Serum Institute of India Private Limited (SIIPL) as the world’s largest manufacturer of vaccines by number of doses and its contribution to India’s […]
Read More